Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)

Oki, E; Emi, Y; Yamanaka, T; Uetake, H; Muro, K; Takahashi, T; Nagasaka, T; Hatano, E; Ojima, H; Manaka, D; Kusumoto, T; Katayose, Y; Fujiwara, T; Yoshida, K; Unno, M; Hyodo, I; Tomita, N; Sugihara, K; Maehara, Y

Oki, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan.

BRITISH JOURNAL OF CANCER, 2019; 121 (3): 222

Abstract

BACKGROUND: Chemotherapy with biologics followed by liver surgery improves the resection rate and survival of patients with colorectal liver metastasi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索